Driver: Favorable reimbursement scenario in developed countries
The developed countries are reported to have favorable reimbursement scenarios for bowel management products, owing to which the demand for these products is expected to grow positively during the study period.
Restraint: Patient preference for non-invasive clinical management of FI
Currently, FI can be managed invasively (surgically) or non-invasively. Standard modes of surgical treatment include the injection of biomaterials into the anal canal, radiofrequency treatment of the anal canal, surgical repair of anal muscle injuries, sacral nerve stimulation, artificial bowel sphincter, muscle transposition to reinforce the anal sphincter, and the creation of a stoma. These often require long-term patient rehabilitation and maybe highly inconvenient and even severely painful.
As a result, the preference has grown for non-invasive approaches, such as the use of disposable products, medications, dietary and lifestyle changes, exercise, biofeedback, bowel training, transanal irrigation, antegrade colonic irrigation, and electrical stimulation. Additionally, these treatment alternatives are considered by surgeons as the first line of treatment as well. The significant adoption and patient preference for non-invasive treatment alternatives are expected to hamper the optimal growth of the bowel management systems market during the forecast period.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45043428
The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5% during the forecast period.
Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient and growing geriatric population, availability of technologically advanced bowel management products, and favorable reimbursement scenario in developed countries.
The colostomy bags segment is expected to form the largest segment during the forecast period.
Based on product, the bowel management systems market is categorized into four major segments, namely, irrigation systems, nerve modulation devices, colostomy bags, and other products & accessories. The colostomy bags segment is expected to account for the largest share in the bowel management systems market in 2018. Increasing number of target patient population, and growing availability of medical reimbursements for colostomy products across developed markets are expected to drive the growth of the colostomy bags segment in the next five years.
Adult patients segment is estimated to register the highest growth rate in the bowel management systems market during the forecast period
The bowel management systems market is segmented, by patient type, into adult and pediatric patients. The adult patients segment is expected to register the highest growth rate in the bowel management systems market during the forecast period, owing to the factors such as the significant prevalence of FI among adults, increased public-private initiatives to enhance patient awareness related to effective FI management, and availability of advanced bowel management products.
The home care segment is estimated to register the highest growth rate in the bowel management systems market during the forecast period
The bowel management systems market is segmented, by end user, into home care and hospitals & ambulatory surgery centers. The home care segment is expected to register the highest growth rate of the bowel management systems market during the forecast period, owing to the factors such as the significant usage and growing adoption of bowel management products in home care settings, and need for device replacement on a regular basis.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=45043428
In 2018, Europe accounted for the largest share of the bowel management systems market
Geographically, the bowel management systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of the market in 2018. The large share can be attributed to the significant disease (colorectal/bladder cancer & IBD) burden, favorable reimbursement scenario, and the increase in its geriatric population.
Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
Wednesday, May 5, 2021
Bowel Management Systems Market - Emerging Trends & Global Future Forecasts
Tuesday, May 4, 2021
Topical Drug Delivery Market worth $129.8 billion by 2025
Expected Revenue Growth:
Respiratory Care Devices Market Size worth $29.9 billion by 2025
The global market is expected to reach USD 29.9 billion by 2025 from USD 16.0 billion in 2019, at a CAGR of -12.5% during the forecast period of 2020 to 2025. Due to the outbreak of coronavirus globally, there is a sudden rise in the demand for respiratory care devices. Thus, the respiratory care devices market witnessed a CAGR of 261.1% between 2019 and 2020. In 2020, the respiratory care devices market reached USD 58.1 billion.
The growth of this market is mainly attributed to the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. However, a lack of awareness leading to a large underdiagnosed and undertreated population and the harmful effects of specific respiratory care devices on neonates have hampered market growth to an extent.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368
Increasing prevalence of COPD to drive the demand for respiratory care devices
Based on indication, COPD held the largest share of the respiratory care devices market in 2019. This is followed by sleep apnea, asthma, and infectious diseases. The large share of the COPD disease segment can be attributed to the increasing prevalence of smoking and environmental factors. This segment is also expected to show the highest growth in the market, followed by asthma.
The hospitals segment accounted for the largest market share in 2019
Based on the end-user, the respiratory care devices market is segmented into hospitals, home care settings, and ambulatory care centers. In 2019, hospitals accounted for the largest market share. Their financial capabilities, which allow them to purchase expensive instruments, and the availability of trained professionals to operate these instruments, have ensured the high percentage of hospitals in this market. Home care settings are expected to witness the highest growth during the forecast period, mainly due to the development of compact and lightweight respiratory care devices that are easier to carry and operate.
Asia Pacific market to witness the highest growth during the forecast period
The respiratory market is divided into five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. These regions are further analyzed at the country levels. North America held the largest share of the respiratory care devices market in 2019, followed by Europe and the Asia Pacific. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, due to due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=368
Global Leaders:
Some of the prominent players operating in this market include Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare (New Zealand), Drager AG (Germany), Invacare Corporation (US), Nihon Kohden (Japan), Getinge AB (Sweden) and Air Liquide (France).
Electrosurgery Market - Major Revenue Growth is Expected in Near Future
The global market is projected to reach USD 8.8 billion by 2025 from USD 6.4 billion in 2019, at a CAGR of 5.2%. The growth in the global electrosurgery market is driven by technological advancements in electrosurgical instruments; the increasing demand for minimally invasive surgeries; the growing number of medical, cosmetic, and age-related surgeries; and the rising number of ambulatory surgery centers. However, risks associated with electrosurgical procedures are expected to restrain the growth of the electrosurgery market.
The electrosurgical instruments segment accounted for the largest share of the electrosurgery market in 2018.
Based on products, the electrosurgery market is segmented into electrosurgical instruments, electrosurgical generators, electrosurgical accessories, and smoke evacuation systems. The electrosurgical instruments segment accounted for the largest share of the global electrosurgery market in 2018. The large share of this segment can be attributed to the high usage volume of disposable and reusable electrosurgical instruments. In addition, technological advancements in electrosurgical instruments and the increasing number of cosmetic and plastic surgeries are stimulating the growth of this segment.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761
The general surgery segment accounted for the largest share of the electrosurgery market in 2018.
On the basis of type of surgery, the electrosurgery market is segmented into general surgery, gynecology surgery, urological surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, neurosurgery, oncological surgery, and other surgeries. The general surgery segment accounted for the largest share of the electrosurgery market in 2018. The large share of this segment can be attributed to the rising geriatric population and the subsequent increase in the prevalence of various diseases/conditions, the growing volume of surgical procedures performed, and the rising prevalence of obesity.
The hospitals, clinics, & ablation centers segment accounted for the largest share of the electrosurgery market in 2018.
On the basis of end users, the electrosurgery market is segmented into hospitals, clinics, & ablation centers; ambulatory surgical centers; and research laboratories & academic institutes. The hospitals, clinics, & ablation centers segment accounted for the largest market share in 2018. The large share of this segment can be attributed to a large number of electrosurgery procedures performed in hospitals, the growing demand for minimally invasive procedures, and the rising adoption of advanced imaging modalities to improve workflow efficiency in hospitals.
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period
On the basis of region, the electrosurgery market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the electrosurgery market, followed by Europe. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing popularity of cosmetic surgeries, government efforts to increase access to elective surgery, large population base, high patient population, and improving healthcare infrastructure in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142006761
Key Players:
In 2018, Medtronic (Ireland), Ethicon (US), and Olympus (Japan) dominated the electrosurgery market. Other prominent players in this market include CONMED (US), B. Braun Melsungen AG (Germany), Applied Medical (Netherlands), Erbe Elektromedizin GmbH (Germany), Kirwan Surgical Products LLC (US), Bovie Medical Corporation (US), BOWA-electronic GmbH & Co. KG (Germany), KLS Martin Group (Germany), Boston Scientific (US), Smith & Nephew plc (UK), and CooperSurgical Inc. (US).
Monday, May 3, 2021
Global ePrescribing Market - Emerging Trends & Future Forecasts
Overview of This Study:
The study involved four major activities in estimating the size of the global ePrescribing market. Exhaustive secondary research was done to collect information on the utilization of different solutions and their regional utilization trends. Industry experts further validated the data obtained through secondary research through primary research.
Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level adoption of various EHR solutions and utilization of ePrescribing funcitonality) and top-down approach (assessment of utilization/adoption/penetration trends, by type of product& service, delivery mode, end user, and region). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910
COVID-19 Impact on ePrescribing Market
The COVID-19 pandemic will not directly impact the e-prescribing market; however, its impact on the healthcare IT and the EMR markets will drive the demand for e-prescribing solutions during and after the global pandemic. Due to the COVID-19 outbreak, the number of teleconsultations has increased. The integration of EHR, telemedicine, and e-prescribing functionalities aid prescribers in creating an interconnected network that ensures the use of HCIT to diagnose and prescribe medicines for patients. In addition, recommendations by the CDC to use telemedicine services and the Drug Enforcement Administration (DEA) regulations for the electronic prescription of controlled substances have increased the number of electronic prescription transactions.
Expected Revenue Growth:
The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%. Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market.
Additionally, the onset of the COVID-19 pandemic has accelerated the use of telemedicine modules and telehealth consultations. This is further driving the adoption of e-prescribing solutions. However, the high cost of deploying e-prescribing solutions, reluctance among healthcare professionals to adopt these solutions, and concerns regarding security and workflow are expected to restrain the growth of this market to a certain extent during the forecast period.
Geographical Growth Scenario:
North America will continue to dominate the ePrescribing market in 2025
In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=910
Global Key Players:
Prominent players in the global e-prescribing market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).
Brain Monitoring Market - Growing Healthcare Market in Emerging Economies
Overview of This Study:
The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.
COVID-19 impact on the global Brain Monitoring market:
The state of urgency to combat the outbreak has led to a significant increase in the demand for remote monitoring and patient engagement solutions. Most of the hospitals/healthcare facilities are currently trying to expand patient monitoring to homecare settings or other temporary setups with an aim to provide optimal care. COVID-19 has led to a significant surge in the demand for ventilators, and manufacturers are currently focusing their efforts to meet the increasing need for ventilators, including other respiratory devices, in contrast to brain monitoring devices. The pandemic is likely to have an adverse impact on the brain monitoring business particularly due to the focus of hospitals in setting up COVID-19 specific ICUs (intensive care units) along with the temporary suspension of production and manufacturing sites in major affected regions across the globe.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=909
Driver: Increasing incidence and prevalence of neurological disorders
The global incidence and prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. Brain disorders, which include a combination of developmental, psychiatric, and neurodegenerative diseases, are a growing cause of morbidity across the globe. This can primarily be attributed to the growing geriatric population (by 2050, more than 20% of the global population is expected to be aged over 65 years). The American Medical Association (AMA) estimates that at least 60% of individuals aged 65 years and above will be living with more than one chronic condition by 2030.
End Users:
Hospitals accounted for the largest share of the end user segment of the brain monitoring market
Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.
North America accounted for the largest share of the global brain monitoring market
North America, Europe, the Asia Pacific, and the Rest of the World. North America held the largest share of the global brain monitoring market in 2019, while the Asia Pacific is projected to be the fastest-growing region in the forecast period. The high growth rate of the market in the Asia Pacific region can be attributed to the availability of low-cost labor and skilled manpower, increase in disposable incomes, rising prevalence of neurodegenerative disorders, and increasing government emphasis on healthcare reforms in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=909
Global Leaders:
Some of the leading players in the Brain Monitoring market include Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Masimo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Neurosoft (Russia), and Rimed (US).
Sleep Apnea Devices Market - Global Industry Growth Dynamics
Growth Boosting Factors:
Growth in the sleep apnea devices market can be attributed to factors such the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets.
Market Dynamics:
Driver: Large pool of undiagnosed sleep apnea patients
Although highly prevalent in the elderly, sleep apnea affects people of all ages and is one of the most common sleep disorders across the globe. The health impact of sleep apnea is quite substantial but under-recognized.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
Worldwide data suggests that sleep apnea impacts more than 936 million people worldwide, which is nearly 10 times greater than previous estimates (Source: ResMed). In the US alone, around 22 million Americans suffer from obstructive sleep apnea (OSA); of which, 80% of moderate and severe OSA cases are undiagnosed [Source: American Sleep Apnea Association (ASAA)]. In the UK, OSA affects an estimated 1.5 million adults; up to 85% of these cases are undiagnosed or untreated. In countries with huge population bases, such as India and China, the diagnosis rate of OSA is <1% (Source: Press Trust of India, 2017 and China.org.cn).
Restraint: High cost of CPAP machines
In most developed countries, the cost of a CPAP device is either reimbursed or provided by medical insurance companies. The main reason for non-adherence is non-acceptance on the part of the patient, mainly due to the mask causing discomfort or claustrophobia. However, conditions are different in most developing countries, where insurance access is minimal and insurance companies usually do not cover the cost of a CPAP device.
In countries like India, CPAP is not covered by private insurance companies. Only some government employees are able to be reimbursed for CPAP therapy, and that too reimbursement ranges from 30% to 100% depending on the reimbursement rules of various government offices. CPAP is generally an out-of-pocket expense for most of the Indian population. This is a major limiting factor for therapy adoption in these countries.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The key players in the industry and markets have been identified through extensive secondary research
The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Opportunity: Increasing focus on telemedicine and mHealth (mobile health)
Several studies have reported that a main predictive factor for long-term CPAP compliance is patient adherence in the first few weeks of treatment. To improve compliance, support and follow-up during this period must be prompt. Telemedicine offers this kind of assistance since long waiting lists make it difficult to provide such support. Several studies suggest that patients in the telemedicine group expressed high satisfaction with their care. They especially liked the convenience of a live video visit with a sleep doctor.
Obstructive sleep apnea is a highly prevalent chronic condition, and telemedicine could play a vital role in the different phases of its management. In the future, using new devices capable of signal acquisition and analysis is expected to refine obstructive sleep apnea diagnosis; even smartphones’ built-in sensors could offer improved comfort and the possibility of home sleep monitoring. Continuous positive airway pressure titration could be performed with wireless devices, whose parameters can be changed remotely from sleep centers. Finally, the follow-up phase could be specially improved by using remote continuous positive airway-pressure data, self-management platforms, and mobile applications for patient feedback.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719
Expected Revenue Gains:
The market for sleep apnea devices is expected to grow from USD 4.5 billion in 2019 to USD 7.5 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.